0 CHECKOUT

Genetics Bundle

  • ID: 680693
  • June 2012
  • Region: Global
  • 1807 Pages
  • TriMark Publications

The Genetics Bundle includes the following reports at a 15% discount off the individual reports being purchased separately:

- Bioinformatics Markets
- DNA Sequencing and PCR Markets
- Gene Expression Reagents Markets
- Genomics World Markets
- Microarray Markets
- Personalized Medicine
- Pharmacogenomics for Clinical Use and in Drug Development
- Regenerative Medicine Markets
- RNA Interference Markets
- Stem Cell Markets

Bioinformatics Markets

The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. It is believed that many of the segments of bioinformatics described in this report offer an unusual opportunity for accelerated expansion within the coming years. This study is arranged to provide an overview of bioinformatics market segments and offer evidence that these segments are poised for significant future growth. Each segment is accompanied by analysis and forecasts by product type and application. This analysis surveys the bioinformatics market and the latest READ MORE >

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

ALSO AVAILABLE

RELATED PRODUCTS

Our Clients

  • Amgen Inc.
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Novartis AG
  • Baxter International Inc.